FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361946827> ?p ?o ?g. }

• W4361946827 abstract "<div>AbstractPurpose:<p>To characterize immune cell expression among patients with non–muscle invasive bladder cancer (NMIBC) treated with Bacillus Calmette-Guerin (BCG).</p>Experimental Design:<p>Patients with NMIBC treated with intravesical BCG (2008–2015) were identified, and a tissue microarray was constructed using paired pre- and post-BCG bladder samples. Among patients undergoing BCG, cystoscopic evaluation began 3 months after initiating BCG treatment to determine therapeutic response. IHC was performed for CD8, CD4, FoxP3, PD-L1 (SP-142 and 22C3), and PD-1. A full slide review of PD-L1⁺ staining tumors was performed to characterize PD-L1 and CD8 colocalization. RNA-seq was performed on cored tumors from available specimens. We compared immune cell populations between BCG responders and nonresponders, and between pretreatment and postreatment tumor samples. Baseline PD-L1 staining in the BCG naïve population was then validated in a separate cohort.</p>Results:<p>The final cohort contained 63 pretreatment NMIBC cases, including 31 BCG responders and 32 BCG nonresponders. No differences in CD4, CD8, or FoxP3 expression were identified between responders and nonresponders. Baseline PD-L1 expression (22C3 and SP-142) was observed in 25% to 28% of nonresponders and 0% to 4% of responders (<i>P</i> < 0.01). PD-L1⁺ cells in BCG nonresponders colocalized with CD8⁺ T cells. In addition, BCG therapy did not increase PD-L1 gene expression (RNA-seq) or protein levels (IHC). The number of pretreatment CD4⁺ T cells was very low among PD-L1⁺ nonresponders (12%) and high among PD-L1⁻ nonresponders (50%, <i>P</i> < 0.01). In a separate cohort of 57 patients with NMIBC undergoing BCG, baseline PD-L1 (22C3) staining was similar (26%).</p>Conclusions:<p>One mechanism of BCG failure may be adaptive immune resistance. Baseline tumor PD-L1 expression predicts an unfavorable response to BCG and if validated, could be used to guide therapeutic decisions.</p></div>" @default.
• W4361946827 created "2023-04-05" @default.
• W4361946827 creator A5002892743 @default.
• W4361946827 creator A5005189001 @default.
• W4361946827 creator A5006140547 @default.
• W4361946827 creator A5006702120 @default.
• W4361946827 creator A5010551367 @default.
• W4361946827 creator A5016811631 @default.
• W4361946827 creator A5031310463 @default.
• W4361946827 creator A5034005227 @default.
• W4361946827 creator A5037573167 @default.
• W4361946827 creator A5046834675 @default.
• W4361946827 creator A5048604566 @default.
• W4361946827 creator A5050196540 @default.
• W4361946827 creator A5059536506 @default.
• W4361946827 creator A5060409090 @default.
• W4361946827 creator A5062308537 @default.
• W4361946827 creator A5077350606 @default.
• W4361946827 creator A5083157531 @default.
• W4361946827 creator A5084357949 @default.
• W4361946827 creator A5086192559 @default.
• W4361946827 creator A5091440000 @default.
• W4361946827 date "2023-03-31" @default.
• W4361946827 modified "2023-10-14" @default.
• W4361946827 title "Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials" @default.
• W4361946827 doi "https://doi.org/10.1158/1078-0432.c.6529610" @default.
• W4361946827 hasPublicationYear "2023" @default.
• W4361946827 type Work @default.
• W4361946827 citedByCount "0" @default.
• W4361946827 crossrefType "posted-content" @default.
• W4361946827 hasAuthorship W4361946827A5002892743 @default.
• W4361946827 hasAuthorship W4361946827A5005189001 @default.
• W4361946827 hasAuthorship W4361946827A5006140547 @default.
• W4361946827 hasAuthorship W4361946827A5006702120 @default.
• W4361946827 hasAuthorship W4361946827A5010551367 @default.
• W4361946827 hasAuthorship W4361946827A5016811631 @default.
• W4361946827 hasAuthorship W4361946827A5031310463 @default.
• W4361946827 hasAuthorship W4361946827A5034005227 @default.
• W4361946827 hasAuthorship W4361946827A5037573167 @default.
• W4361946827 hasAuthorship W4361946827A5046834675 @default.
• W4361946827 hasAuthorship W4361946827A5048604566 @default.
• W4361946827 hasAuthorship W4361946827A5050196540 @default.
• W4361946827 hasAuthorship W4361946827A5059536506 @default.
• W4361946827 hasAuthorship W4361946827A5060409090 @default.
• W4361946827 hasAuthorship W4361946827A5062308537 @default.
• W4361946827 hasAuthorship W4361946827A5077350606 @default.
• W4361946827 hasAuthorship W4361946827A5083157531 @default.
• W4361946827 hasAuthorship W4361946827A5084357949 @default.
• W4361946827 hasAuthorship W4361946827A5086192559 @default.
• W4361946827 hasAuthorship W4361946827A5091440000 @default.
• W4361946827 hasConcept C121608353 @default.
• W4361946827 hasConcept C126322002 @default.
• W4361946827 hasConcept C167672396 @default.
• W4361946827 hasConcept C193270364 @default.
• W4361946827 hasConcept C203014093 @default.
• W4361946827 hasConcept C204232928 @default.
• W4361946827 hasConcept C2776090121 @default.
• W4361946827 hasConcept C2779727006 @default.
• W4361946827 hasConcept C2780352672 @default.
• W4361946827 hasConcept C2908647359 @default.
• W4361946827 hasConcept C71924100 @default.
• W4361946827 hasConcept C8891405 @default.
• W4361946827 hasConcept C90924648 @default.
• W4361946827 hasConcept C99454951 @default.
• W4361946827 hasConceptScore W4361946827C121608353 @default.
• W4361946827 hasConceptScore W4361946827C126322002 @default.
• W4361946827 hasConceptScore W4361946827C167672396 @default.
• W4361946827 hasConceptScore W4361946827C193270364 @default.
• W4361946827 hasConceptScore W4361946827C203014093 @default.
• W4361946827 hasConceptScore W4361946827C204232928 @default.
• W4361946827 hasConceptScore W4361946827C2776090121 @default.
• W4361946827 hasConceptScore W4361946827C2779727006 @default.
• W4361946827 hasConceptScore W4361946827C2780352672 @default.
• W4361946827 hasConceptScore W4361946827C2908647359 @default.
• W4361946827 hasConceptScore W4361946827C71924100 @default.
• W4361946827 hasConceptScore W4361946827C8891405 @default.
• W4361946827 hasConceptScore W4361946827C90924648 @default.
• W4361946827 hasConceptScore W4361946827C99454951 @default.
• W4361946827 hasLocation W43619468271 @default.
• W4361946827 hasOpenAccess W4361946827 @default.
• W4361946827 hasPrimaryLocation W43619468271 @default.
• W4361946827 hasRelatedWork W170838013 @default.
• W4361946827 hasRelatedWork W2078792455 @default.
• W4361946827 hasRelatedWork W2080780959 @default.
• W4361946827 hasRelatedWork W2366649094 @default.
• W4361946827 hasRelatedWork W2408605056 @default.
• W4361946827 hasRelatedWork W2465231198 @default.
• W4361946827 hasRelatedWork W2472423817 @default.
• W4361946827 hasRelatedWork W2731779973 @default.
• W4361946827 hasRelatedWork W4285095339 @default.
• W4361946827 hasRelatedWork W4313369199 @default.
• W4361946827 isParatext "false" @default.
• W4361946827 isRetracted "false" @default.
• W4361946827 workType "article" @default.